4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001177648-19-000009
President and CEO gave up 20,730 shares (to pay taxes)
- President and CEO acquired 50,400 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Luly Jay R. · President and CEO
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2019-02-12 | Grant or award : show line 1 in the form | +14,400 | 615,924 | D | ||
| 2019-02-12 | Grant or award : show line 2 in the form | +36,000 | 651,924 | D | ||
| 2019-02-12 | Shares withheld for taxes : show line 3 in the form | −20,730 | $88.88 | $1,842,482 | 631,194 | D |
Loading xslF345X03/edgar.xml…